Arkolith/Insider Trading/LCTX/Form 4

Broadwood Partners, L.P.

Director, 10% OwnerLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Feb 8, 2024
Net Buying
Open-Market Buys
$7.0M
Open-Market Sells
$0
Net Open-Market Flow
$7.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2024Buy(P)0—$041.7M
Feb 6, 2024Buy(P)6.7M$1.04$7.0M41.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-24-000757) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML